Takip et
Esen Saka (Esen Saka Topçuoğlu)
Esen Saka (Esen Saka Topçuoğlu)
hacettepe.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
3342012
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 274-284, 2017
1622017
Repetitive behaviors in monkeys are linked to specific striatal activation patterns
E Saka, C Goodrich, P Harlan, BK Madras, AM Graybiel
Journal of Neuroscience 24 (34), 7557-7565, 2004
1532004
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 285-295, 2017
1472017
Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation
E Saka, M Iadarola, DJ Fitzgerald, AM Graybiel
Proceedings of the National Academy of Sciences 99 (13), 9004-9009, 2002
1112002
Pathophysiology of Tourette's syndrome: striatal pathways revisited
E Saka, AM Graybiel
Brain and Development 25, S15-S19, 2003
932003
Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer's disease and mild cognitive impairment in Turkish people
E Saka, E Mihci, MA Topcuoglu, S Balkan
Archives of Clinical Neuropsychology 21 (7), 745-751, 2006
902006
Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy
JR Crittenden, I Cantuti-Castelvetri, E Saka, CE Keller-McGandy, ...
Proceedings of the National Academy of Sciences 106 (8), 2892-2896, 2009
762009
Short latency afferent inhibition in Parkinson's disease patients with dementia
O Celebi, ÇM Temuçin, B Elibol, E Saka
Movement disorders 27 (8), 1052-1055, 2012
672012
Recrudescence of deficits after stroke: clinical and imaging phenotype, triggers, and risk factors
MA Topcuoglu, E Saka, SB Silverman, LH Schwamm, AB Singhal
JAMA neurology 74 (9), 1048-1055, 2017
642017
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
A Eker, E Saka, J Dalmau, A Kurne, C Bilen, H Ozen, D Ertoy, KK Ouz, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (9), 1082-1083, 2008
642008
Thymus changes in anti-MuSK-positive and-negative myasthenia gravis
E Saka, MA Topcuoglu, B Akkaya, A Galati, MZ Onal, A Vincent
Neurology 65 (5), 782-783, 2005
542005
Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease
G Hacioglu, Y Seval-Celik, G Tanriover, O Ozsoy, E Saka-Topcuoglu, ...
Folia histochemica et cytobiologica 50 (2), 228-238, 2012
512012
Alzheimer hastalığı
ES Topçuoğlu, K Selekler
Geriatri 1 (2), 63-67, 1998
501998
Occipital cortex activation studied with simultaneous recordings of functional transcranial Doppler ultrasound (fTCD) and visual evoked potential (VEP) in cognitively normal …
MA Topcuoglu, H Aydın, E Saka
Neuroscience letters 452 (1), 17-22, 2009
482009
A genetic basis for obsessive grooming
AM Graybiel, E Saka
Neuron 33 (1), 1-2, 2002
452002
Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment
E Saka, B Elibol, S Erdem, T Dalkara
Brain research 825 (1-2), 104-114, 1999
441999
Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive …
E Saka, EA Dogan, MA Topcuoglu, U Senol, S Balkan
Archives of gerontology and geriatrics 44 (2), 141-151, 2007
432007
Turkish standardization of movement disorders society unified Parkinson's disease rating scale and unified dyskinesia rating scale
MC Akbostanci, E Bayram, V Yilmaz, S Rzayev, S Özkan, AB Tokcaer, ...
Movement disorders clinical practice 5 (1), 54-59, 2018
412018
Epigenetic approach to early-onset Parkinson’s disease: low methylation status of SNCA and PARK2 promoter regions
IE Eryilmaz, G Cecener, S Erer, U Egeli, B Tunca, M Zarifoglu, B Elibol, ...
Neurological research 39 (11), 965-972, 2017
412017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20